Published Articles
  Red cell folate assays: some answers to current problems with radioassay variability. Pathology 1990;22: 82-87.  
  Brown RD, Jun R, Hughes W, Watman R, Arnold B, Kronenberg H   
  Published: 1990  
  Laboratory testing, diagnosis and management of von Willebrand's disease: Current practice in Australasia. American Journal of Clinical Pathology, 1999; 112:712-719.  
 

Favaloro EJ,  Smith J,  Petinos P,  Collecutt M,  Street A,  Hertzberg M, (on behalf of the RCPA Quality Assurance Program (QAP) in Haematology Scientific Haemostasis Advisory Panel).

 
  Published: 1999  
  Laboratory testing for von Willebrand's disease: An assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. Thrombosis & Haemostasis, 1999; 82:1276-1282.  
  Favaloro EJ,  Smith J,  Petinos P,  Hertzberg M, Koutts J, (on behalf of the RCPA Quality Assurance Program (QAP) in Hematology Scientific Hemostasis Advisory Panel).  
  Published: 1999  
  Laboratory diagnosis of von Willebrand Disorder: Current practice in the Southern Hemisphere. American Journal of Clinical Pathology, 2003; 119:882-893.  
 

Favaloro EJ, Bonar R, Sioufi J, Hertzberg M, Street A, Lloyd J, Marsden K (on behalf of the RCPA QAP in Haematology Haemostasis Committee).

 		 
  Published: 2003  
  Australasian CD34+ Quality Assurance Program and rationale for the clinical utility of the single platform method for CD34+ cell enumeration  
  Chang A, Raik E, Marsden K, Ma DDF. Cytotherapy, 2004; 6: 50-61  
  Published: 2004  
  Laboratory diagnosis of von Willebrand Disorder: Quality and diagnostic improvements driven by peer review in a multi laboratory test process  
 

Favaloro EJ, Bonar R, Kershaw G, Sioufi J, Hertzberg M, Street A, Lloyd J, Marsden K (on behalf of the RCPA QAP in Haematology Haemostasis Committee).  Haemophilia 2004; 10:232-242.

 
  Published: 2004  
  Laboratory diagnosis of von Willebrand Disorder: Quality and diagnostic improvements driven by peer review in a multi-laboratory test process.Haemophilia, 2004, 10; 232?242.  
  Favaloro EJ, Bonar R, Kershaw G, Sioufi J,  Hertzberg M, Street A, Lloyd J, Marsden K (on behalf of the RCPA QAP in Haematology).  
  Published: 2004  
  External quality assurance of DNA testing for thrombophilia mutations. American Journal of Clinical Pathology, 2005, 123: 189-193.  
  Hertzberg M, Neville S, Favaloro EJ, MacDonald D.  
  Published: 2005  
  Multi-laboratory testing of thrombophilia: Current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program in Haematology. Seminars in Thrombosis and Hemostasist, 2005; 31: 49-58.  
  Favaloro EJ, Bonar R, Sioufi J, Wheeler M, Low J, Aboud M, Duncan E, Smith J, Exner T, Lloyd J, Marsden K (on behalf of the RCPA QAP in Haematology).  
  Published: 2005  
  An international survey of current practice in the laboratory assessment of anticoagulant therapy with heparin. Pathology, 2005; 37: 234-238.  
  Favaloro EJ, Bonar R, Sioufi J, Wheeler M, Low J, Aboud M, Lloyd J, Street A, Marsden K (on behalf of the RCPA QAP in Haematology).  
  Published: 2005  
  How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? The laboratory perspective. Laboratory Haematology, 2005;11:157-162.  
  Favaloro EJ, Bonar R, Aboud M, Low J, Sioufi J, Wheeler M, Lloyd J, Street A, Marsden K (on behalf of the RCPA QAP in Haematology).  
  Published: 2005  
  Reducing errors in identification of von Willebrand disease: The experience of the Royal College of Pathologists of Australiasia. Seminars in Thrombosis and Hemostasis, 2006; 32: 505-513.  
  Favaloro EJ, Bonar R, Kershaw G, Sioufi J, Baker R, Hertzberg M, Street A, Marsden K (on behalf of the RCPA QAP in Haematology).  
  Published: 2006  
  Identification of factor Inhibitors by diagnostic laboratories: A large multi-centre evaluation. Thrombosis and Haemostasis 2006; 96: 73-78.  
  Favaloro EJ, Bonar R, Earl G, Low J, Aboud M, Duncan E, Just S, Sioufi J, Street A, Marsden K (on behalf of the RCPA QAP in Haematology Haemostasis Committee).  
  Published: 2006  
  2B or not 2B? Disparite discrimination of functional VWF discordance using different assay panels or methodologies may lead to success or failure in the early identification of type 2b VWD.  
  Emmauel J. Favaloror, Roslyn Boar, Muriel Meiring, Alison Street, Katherine Marsden, on behalf of the RCPA QAP in Haematology.  
  Published: 2007